Physicians' Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Physicians' Education Resource®, LLC, designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity is supported by educational grants from Bristol-Myers Squibb, Ferring, Merck, Novartis, and Sanofi.
This activity is designed to update physicians on the data that has been recently presented at major cancer conferences so they can assess and prepare to apply these findings to their clinical practice to improve patient care.
Instructions For This Activity & Receiving Credit
This educational activity is directed toward medical, surgical, and radiation oncologists involved in the treatment of patients with GU malignancies. Urologists, fellows, nurse practitioners, nurses, physician assistants, pharmacists, researchers, nuclear medicine physicians, and other healthcare professionals interested in the treatment of GU malignancies may also participate.
Oliver Sartor, MD
Laborde Professor for Cancer Research
Medical Director Tulane Cancer Center
Tulane Medical School
New Orleans, LA
Disclosure: Grant/Research Support: Sanofi, AstraZeneca; Consultant: Sanofi, AstraZeneca.
Sumanta Kumar Pal, MD
Assistant Clinical Professor, Department of Medical Oncology & Therapeutics Research
Co-director, Kidney Cancer Program
City of Hope Comprehensive Cancer Center
Disclosure: Consultant: Pfizer, GSK, Novartis, Genentech, Exelixis, BMS; Speaker’s Bureau: Genentech.
The following individuals have no relevant financial relationships with commercial interests:
The staff of PER®, LLC.
It is the policy of Physicians' Education Resource®, LLC, (PER®) to ensure fair balance, independence, objectivity, and scientific rigor in all of our CME activities. In accordance with ACCME guidelines, PER® requires everyone who is in a position to control the content of an educational activity, including spouses/partners, to disclose all relevant financial relationships with any commercial interest to participants as a part of the activity planning process. PER® has implemented mechanisms to identify and resolve all conflicts of interest prior to release of this activity.
This CME activity may or may not discuss investigational, unapproved, or off-label uses of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME activity is for continuing medical education purposes only, and is not meant to substitute for the independent medical judgment of a physician or nurse relative to diagnostic, treatment, or management options for a specific patient's medical condition.
The opinions expressed in the content are solely those of the individual faculty members, and do not reflect those of Physicians’ Education Resource®, LLC, or any of the companies that provided commercial support for this activity.
Oncology Briefings™: Updates in Therapeutic Options and Approaches for Tenosynovial Giant Cell Tumors
Apr 28, 2018
April 28, 2018
New York, NY